39,681 Shares in Cardinal Health, Inc. $CAH Acquired by Cibc World Market Inc.

Cibc World Market Inc. purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) during the second quarter, according to its most recent filing with the SEC. The firm purchased 39,681 shares of the company’s stock, valued at approximately $9,427,000.

A number of other institutional investors also recently added to or reduced their stakes in CAH. University of Texas Texas AM Investment Management Co. purchased a new stake in shares of Cardinal Health during the fourth quarter valued at about $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the 4th quarter worth approximately $27,000. Jones Financial Companies Lllp grew its position in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Palladiem LLC bought a new position in shares of Cardinal Health during the 4th quarter worth approximately $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in Cardinal Health during the first quarter valued at approximately $29,000. Institutional investors own 87.17% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CAH. Evercore reaffirmed an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Leerink Partners set a $292.00 price objective on Cardinal Health in a report on Tuesday, August 11th. Bank of America boosted their target price on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research note on Thursday, July 2nd. Zacks Research lowered Cardinal Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 12th. Finally, William Blair began coverage on shares of Cardinal Health in a report on Tuesday, April 28th. They issued an “outperform” rating for the company. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $266.56.

Insider Buying and Selling at Cardinal Health

In related news, insider Michelle D. Greene sold 11,650 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total value of $2,746,138.00. Following the completion of the sale, the insider owned 10,330 shares of the company’s stock, valued at approximately $2,434,987.60. The trade was a 53.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Deborah Weitzman sold 7,354 shares of the company’s stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total transaction of $1,731,499.30. Following the transaction, the chief executive officer owned 77,901 shares of the company’s stock, valued at $18,341,790.45. This represents a 8.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by corporate insiders.

Key Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Cardinal Health Stock Up 1.1%

CAH stock opened at $232.13 on Tuesday. The company’s 50-day simple moving average is $232.13 and its 200-day simple moving average is $217.96. Cardinal Health, Inc. has a 52-week low of $145.87 and a 52-week high of $258.30. The firm has a market cap of $53.99 billion, a P/E ratio of 32.11, a PEG ratio of 1.23 and a beta of 0.49.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.42 by $0.49. The firm had revenue of $63.67 billion during the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.Cardinal Health’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 12.54 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be given a $0.5158 dividend. The ex-dividend date is Thursday, October 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.9%. Cardinal Health’s payout ratio is 28.49%.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.